Proprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation.

Gardado en:
Detalles Bibliográficos
Publicado en:J Biol Chem
Main Authors: Weider, Elodie, Susan-Resiga, Delia, Essalmani, Rachid, Hamelin, Josée, Asselin, Marie-Claude, Nimesh, Surendra, Ashraf, Yahya, Wycoff, Keith L., Zhang, Jianbing, Prat, Annik, Seidah, Nabil G.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Biochemistry and Molecular Biology 2016
Assuntos:
Additions and Corrections
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159516/
https://ncbi.nlm.nih.gov/pubmed/27986868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.A116.717736
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares